Fort Worth, Texas — Albert Wayne Kidd recently received the news he had been hoping for: his scans were clear and he is cancer-free after undergoing chimeric antigen receptor (CAR) T-cell therapy and follow-up care in Fort Worth. Medical City Fort Worth is the first hospital in Tarrant County to implement a patient monitoring and management protocol for chimeric antigen receptor (CAR) T-cell therapy patients following outpatient infusions, reinforcing its commitment to delivering advanced oncology services in the region.
Medical City Fort Worth served as the hospital-based site for expected adverse event monitoring and inpatient management during the post-infusion phase of treatment for Kidd, a 62-year-old from Bowie, Texas. A longtime Tarrant County resident, Kidd said receiving care in Fort Worth was important to him because of his connection to the community and its proximity to his current home. This role is a critical component of the CAR-T therapy continuum of care and requires specialized clinical expertise, rapid-response capabilities and close coordination with certified CAR-T treatment centers.
Kidd says the care he received at Medical City Fort Worth made a difficult journey easier and he looks forward to getting back to everyday life with his family.
The program will significantly increase patient access to CAR-T therapy, an advanced form of cellular treatment that uses the body’s immune system to combat cancer. CAR-T therapy works by modifying a patient’s T-cells so they can identify and eliminate cancer cells, offering a leading-edge, highly personalized approach to oncology care.
“By extending access to CAR-T therapy, we are advancing our mission to bring innovative, life-saving treatments closer to where our patients live,” says Bibas Reddy, DO, oncology medical director. “Ensuring that hospital-based teams are fully equipped to monitor and manage patients during the post-infusion phase is critical to promoting safe recovery and achieving the best possible outcomes.”
By supporting this innovative cellular treatment technology, Medical City Fort Worth reinforces its commitment to system-wide excellence and advancing care and research in North Texas.
“Supporting patients through advanced therapies like CAR-T treatment requires exceptional teamwork, clinical readiness and strong partnerships,” says John Hoover, Medical City Fort Worth CEO. “Our investment in these capabilities strengthens our systems of care and access to specialized care for patients throughout North Texas.”
Through its oncology program, Medical City Fort Worth continues to invest in specialized training, infrastructure and multidisciplinary collaboration to support emerging therapies and evolving standards of care for patients across Tarrant County and surrounding communities.
Medical City Fort Worth is accredited by the American College of Surgeons Commission on Cancer, demonstrating its commitment to high-quality, multidisciplinary, patient-centered cancer care and continuous performance improvement.
For more information about oncology services, visit the Medical City Fort Worth website.